Expansion of the CD8 T-cell memory pool, also known as 'memory inflation', for certain but not all viral epitopes in latently infected host tissues is a special feature of the immune response to cytomegalovirus. The L d -presented murine cytomegalovirus (mCMV) immediate-early (IE) 1 peptide is the prototype of an epitope that is associated with memory inflation. Based on the detection of IE1 transcripts in latently infected lungs it was previously proposed that episodes of viral gene expression and antigenic activity due to desilencing of a limited number of viral genes may drive epitope-specific memory inflation. This would imply direct antigen presentation through latently infected host tissue cells rather than cell death-associated cross-presentation of viral antigens derived from productively infected cells through uninfected, professional antigenpresenting cells (profAPCs). To address the role of bone marrow-derived profAPCs in CD8 T-cell priming and memory to mCMV, we have used here a combined sex-mismatched and MHC class-I mismatched dual-marker bone marrow chimera model in which presentation of the IE1 epitope is restricted to donor-derived sry + L d+ cells of haematopoietic differentiation lineages. Successful CD8 T-cell priming specific for the L d -and D d -presented inflationary epitopes IE1 and m164, respectively, but selective failure in IE1 epitope-specific memory inflation in these chimeras indicates different modes of antigen presentation involved in CD8 T-cell priming and memory inflation. These data suggest that memory inflation during mCMV latency requires expression of the epitope-presenting MHC class-I molecule by latently infected non-haematopoietic host tissue cells and thus predicts a role for direct antigen presentation in memory inflation.
INTRODUCTION
It is current opinion that priming of CD8 T-cells during acute viral infections is accomplished mainly by uninfected professional antigen-presenting cells (profAPCs) that take up and 'cross-present' viral antigens derived from infected cells undergoing infection-associated cell death (den Haan & Bevan, 2001; Heath & Carbone, 2001; Kurts et al., 2010; Shen & Rock, 2006) . For the infection with murine cytomegalovirus (mCMV), comparably efficient priming of CD8 T-cells in the presence and absence of 'viral inhibitors of direct antigen presentation', known as immunoevasins (for reviews, see Doom & Hill, 2008; Hansen & Bouvier, 2009; Lemmermann et al., 2011a; Reddehase, 2002) , provided a reasonable argument for priming by cross-presentation (Böhm et al., 2008; Gold et al., 2002; Munks et al., 2007) . More direct evidence for cross-presentation of mCMV epitopes was provided only recently by in vivo priming of CD8 T-cells with MHC class-I (MHC-I)-deficient fibroblasts infected with a spreaddefective virus mutant, mCMV-DgL, conditions which plausibly prevent any direct antigen presentation (Snyder et al., 2010) . A potent cross-presenting cell type is the CD8 + CD11c + subset of dendritic cells (DCs) (Allan et al., 2003; Belz et al., 2004; Schnorrer et al., 2006) , which are bone marrow (BM)-derived haematopoietic cell progeny. Usually, after the primary response to infection and first wave of antigen-driven proliferation, the numbers of viral epitope-specific CD8 T-cells contract and central memory cells are maintained in low numbers (Klenerman & Dunbar, 2008) . It is a special feature of the immune response to both human cytomegalovirus (hCMV) (reviewed by Wills et al., 2006) and mCMV (Holtappels et al., 2000; Karrer et al., 2003; Munks et al., 2006a ) that after this contraction phase, which coincides with the clearance of productive infection and establishment of latent infection, memory cells specific for certain viral epitopes expand again in number with decreasing polyclonality, and acquire and maintain an activated CD62L low phenotype (reviewed by Wiesel et al., 2009) . As shown for mCMV, these cells form infiltrates at extra-lymphoid tissue sites such as the lungs (Podlech et al., 2000) , a major organ site of mCMV latency (Balthesen et al., 1993; Kurz et al., 1997) . This phenomenon of memory expansion is also known as 'memory inflation', and epitopes for which memory expands or not expands were classified as 'inflationary' or 'non-inflationary' epitopes, respectively. The MHC-I L d -presented immediate-early (IE) epitope IE1 (Reddehase et al., 1989 ) is the prototype of an inflationary epitope of mCMV (Holtappels et al., 2000) .
The obvious question of why some epitopes drive memory inflation while others do not still awaits the answer. Notably, the magnitude of the primary immune response to an epitope does not predict memory inflation (Munks et al., 2006a ). An intrinsic property of CD8 T-cells of certain T-cell receptor (TCR) specificities and/or affinities or an influence of the size of the naïve T-cell repertoire appear to be an unlikely explanation in view of the finding that the IE1 epitope drives memory inflation only when expressed in the context of mCMV infection but not when expressed in a vaccinia virus recombinant (Karrer et al., 2003) . Thus, the underlying mechanism must somehow relate to the specific biology of mCMV. As mCMV, unlike vaccinia virus, establishes a lifelong latent infection, it has been an immediate idea that viral genes encoding inflationary epitopes might possibly be expressed in latently infected cells at least intermittently, resulting in sporadic peptide presentation and consequent memory cell restimulation (Holtappels et al., 2000) . Such gene expression episodes, including past episodes, are thought to be most sensitively 'memorized' by memory cells, even if such episodes remain undetectable by conventional molecular methods. For IE1 memory inflation, this concept was supported by the detection of correctly spliced IE1 transcripts in latently infected lungs (Grzimek et al., 2001; Kurz et al., 1999) and by the detection of higher levels of IE1 transcripts in lungs latently infected with mutant virus mCMV-IE1-L176A, in which IE1-specific immune control is selectively prevented by point mutation of the C-terminal amino acid residue of the IE1 peptide (Simon et al., 2006 ; for a review, see Lemmermann et al., 2011b) . As a further corroborative evidence, unrelated transgenic epitopes, if expressed under the control of the mCMV major IE enhancer-promoter, were found to acquire the characteristics of inflationary epitopes (Karrer et al., 2004) . From all this it was proposed that memory cells sense and terminate episodes of viral gene expression during latency (reviewed by .
A recently raised argument against CD8 T-cell memory inflation by repetitive restimulation was the absence of CD4 T-cell memory inflation specific for an epitope in protein IE3, a protein that also contains an inflationary CD8 T-cell epitope (Arens et al., 2008) . This objection, however, did not consider the possibility that memory inflation may be driven by direct antigen presentation in latently infected non-haematopoietic MHC class-II (MHC-II)-negative host tissue cells, which would explain why memory inflation during mCMV latency appears to be a feature of MHC-I-restricted CD8 T-cells but not of MHC-II-restricted CD4 T-cells. The identification of the type of APC involved in memory inflation, either profAPCs of haematopoietic origin or stromal and parenchymal tissue cells, is therefore an important missing link for a better understanding of memory inflation associated with viral latency.
Here, we provide data supporting the interpretation that memory inflation during mCMV latency requires epitope presentation by latently infected non-haematopoietic host tissue cells.
RESULTS

Characterization of bone marrow chimeras expressing the IE1 epitope-presenting MHC-I molecule selectively on cells of haematopoietic lineages
Clinical BM transplantation (BMT) after haematoablative treatment of recipients is an established therapeutic approach to replace malignant haematopoietic cells of a recipient with healthy haematopoietic cells of a donor. The BMT model was used here in a dual-marker version to distinguish between donor-derived haematopoietic profAPCs and recipients' cells ( Fig. 1) . Specifically, male et al., 1998) and that the two mouse strains are co-isogenic, sharing minor histocompatibility antigens, so that donorderived cells are not destroyed by a host-versus-graft reaction. By using the pan-genomic library of mCMV-ORF expression plasmids established by Munks et al. (2006b) , we first characterized the acute and memory CD8 T-cell responses to mCMV in immunocompetent mice of the chosen donor and recipient mouse strains (Fig. 2) . At a glance, antigenicity profiles in the acute response are comparable between the two strains, except the expected
. The broader specificity repertoire of the acute response focuses on the known two dominant specificities IE1 and m164 in the memory response in BALB/c (Holtappels et al., 2002b) and, logically, just to the D d -restricted m164 epitope in BALB/c-H-2 dm2 mice.
For BMT, mCMV-naïve female recipients received haematoablative conditioning before BM cells from male mCMVnaïve donors were transferred, followed by intraplantar infection (Fig. 1) . Successful repopulation of the recipients' BM with donor haematopoietic cells was monitored by sry-specific quantitative PCR (qPCR), revealing efficient replacement of recipient-genotype with donor-genotype haematopoietic cells in H-2dxdm2 chimeras (Fig. 3a) . (Fig. 3b) . Finally, in spleen ( Fig. 3c ; c1, c2) and lungs ( Fig. 3c; 
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+ DC subset thereof expressed L d and were 
Most of the IE1 peptide in the lungs after BMT is processed in non-haematopoietic cells
Macrophages and DCs are targets of productive mCMV infection and are, in principle, capable of IE1 peptide processing and direct presentation (Andrews et al., 2001; Benedict et al., 2008; Dalod et al., 2003; Hengel et al., 2000; Holtappels et al., 2006) . In addition, uninfected DCs can take up and process viral proteins for peptide crosspresentation (see Introduction). Nevertheless, quantification of processed IE1 peptide from lungs during acute infection after BMT revealed that L d+ haematopoietic lung infiltrate cells account for only low amounts of IE1 peptide in H-2dxdm2 chimeras when compared with L d+ haematopoietic plus non-haematopoietic lung cells in 
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H-2dxd homo-chimeras (Fig. 4a, b) . This relates to the fact that in the immunocompromised host mCMV replicates in a variety of non-haematopoietic stromal and parenchymal cell types , including pneumocytes, fibrocytes and endothelial cells of the lungs (Reddehase et al., 1985) . One may miss here the reciprocal model of H2dm2xd chimeras, in which IE1 peptide processing would formally be restricted to recipients' cells. In this specific constellation, however, recipients die of multiple organ CMV disease due to a failure in immune control (under investigation). IE1 peptide was undetectable in H2dm2xdm2 homo-chimeras (Fig. 4c) , an expected finding that is explained by peptide degradation in the absence of the presenting MHC-I molecule (Del Val et al., 1991; Falk et al., 1990) . This negative control confirms the conclusion that IE1 peptide isolated from H-2dxdm2 chimeras is produced by processing in donor-derived haematopoietic cells only.
Theoretically, a lower amount of processed IE1 peptide during the acute infection in H-2dxdm2 chimeras could reflect also a lower viral productivity and thus a lower antigen load. This alternative explanation was ruled out by comparable viral productivity and clearance kinetics in H2dxd, H-2dxdm2 and H-2dm2xdm2 chimeras (Fig. 5 ). This finding suggests that the observed differences in the amounts of IE1 peptide do not result from differences in the overall viral replication but instead reflect the cellular distribution of the IE1 peptide-presenting L d molecule in the different chimeras. From the low amount of IE1 peptide present in the lungs of H-2dxdm2 chimeras we thus conclude that profAPCs are only a minor source of processed IE1 peptide under the experimental conditions studied herein.
Chimerism does not significantly influence viral genome load and epitope-encoding gene expression during latency
To comply with the hypothesis of memory inflation driven by antigenic activity of latently infected cells, epitopeencoding genes must be expressed during latency. Accordingly, differences between the chimeras in viral genome load and transcriptional activity during latency would affect the provision of antigenic peptides for presentation and should thus have an impact on memory inflation. Specifically, in addition to the presence or absence of the IE1 epitope-presenting L d molecule on latently infected cell types, differences in IE1 gene expression during latency could influence IE1-specific memory inflation. This possibility needed to be addressed.
Like in our previous work on mCMV latency (reviewed by , latency was here defined by the presence of the viral genome in tissues after its PCRverified clearance from BM and blood, and by absence of infectivity at all typical organ sites of mCMV replication, including the salivary glands, a privileged site of delayed mCMV clearance (for a review, see Campbell et al., 2008) . Residual low-level productive infection was most rigorously excluded by centrifugal infection of highly permissive mouse embryo fibroblast cell cultures with organ homogenate, followed by incubation for three cycles of multistep viral growth (72 h) and quantification of IE1 transcripts. The sensitivity of this assay has been shown to be 0.01 noncentrifugal p.f.u. per culture, which corresponds tõ 2610 29 p.f.u. per cell (Kurz et al., 1997) . At a time when infectivity was undetectable with this assay in the lungs of both H-2dxd and H-2dxdm2 chimeras (negative data not shown), latent viral genome load (Fig. 6a) as well as the amount of IE1 transcripts (Fig. 6b) did not differ statistically, albeit there appeared to be a tendency to an even somewhat higher load and transcriptional activity in the H-2dxdm2 chimeras. So, in case memory inflation would be driven by latently infected or cross-presenting donor-derived L d+ profAPCs, there was no reason for a failure in IE1-specific memory inflation in H-2dxdm2 chimeras.
profAPCs are not sufficient for driving memory inflation during mCMV latency
Based on all these conditions, acute and memory CD8 T-cell responses to the two dominant epitopes IE1 and m164 were monitored for a period of 6 months, that is from acute infection to latency (Fig. 7) . In accordance with successful physical repopulation of donor-derived L d+ profAPCs (Fig. 3) and with low but detectable IE1 peptide processing (Fig. 4b) , IE1-specific CD8 T-cells were indeed primed in the H-2dxdm2 chimeras (Fig. 7a) , indicating that repopulation of the recipients with profAPCs was also functional and implying that IE1-specific CD8 T-cells were not missing in the reconstituted repertoire. Moreover, there was no notable quantitative difference to the IE1-specific priming in H2dxd homo-chimeras (Fig. 7b) , which may relate to the fact that the donor cells, and thus the transplanted T-cell progenitor repertoire, was exactly the same for both types of chimeras. In this context it is important to note that T-cell reconstitution in this model is thymus-dependent, as revealed by absence of T-cells in H-2dxdm2 chimeras generated with thymectomized recipients (negative data not shown). Thus, detection of IE1-specific CD8 T-cells during the acute response in H-2dxdm2 chimeras that lack expression of the epitope-presenting L d molecule on thymic epithelial cells probably indicates thymic education of newly developing T-cells accomplished by BM-derived, reconstituted L d+ thymic DCs (for reviews on thymic antigen presentation, see Derbinski & Kyewski, 2010; Klein et al., 2009) . Importantly, IE1-specific CD8 T-cells were also primed in H-2dxdm2 chimeras established prior to infection (data not shown), which implies that the reconstitution of the virus-specific naïve T-cell repertoire does not require the presentation of viral antigens by thymic DCs.
After the contraction phase, however, IE1-specific memory cells conspicuously failed to expand in lungs and spleen selectively in the H-2dxdm2 chimeras. Importantly, in the very same mice, memory expansion specific for the inflationary m164 epitope presented by MHC-I D d , which is shared by donor and recipient cells, provided an internal positive control verifying that the failure in IE1-specific memory inflation does not reflect a more general deficiency in BM chimeras but in fact relates specifically to missing IE1-epitope presentation by L d-tissue cells. It should be mentioned that this important control is unavailable in C57BL/6-based models, where coincidentally all currently known inflationary epitopes share the presenting K b allele (Munks et al., 2006a) .
Finally, in an independent experiment (Fig. 8) , selective lack of IE1-specific memory inflation in the lungs of H2dxdm2 chimeras was verified also by epitope-specific TCR staining with MHC-peptide multimers, whereas m164-specific CD8 T-cells in H-2dxdm2 chimeras as well as both IE1-and m164-specific CD8 T-cells in H-2dxd homochimeras were found in significant numbers. Notably, the majority of epitope-specific CD8 T-cells displayed the phenotype CD62L -KLRG1 + that is characteristic of sensitized cells under conditions of persistent or repetitive antigen stimulation (Thimme et al., 2005) .
DISCUSSION
In contrast to the current view of hCMV latency localizing predominantly to haematopoietic cells of the myeloid 
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lineage (reviewed by Reeves & Sinclair, 2008) , which include profAPCs, there is increasing evidence for mCMV latent genomes localizing primarily to non-haematopoietic tissue cells. In fact, already historic work by the group of D. Spector (Mercer et al., 1988) has provided the first evidence for mCMV latency in MHC-II -sinusoidal lining cells of the spleen. More recently, the liver sinusoidal endothelial cell, which displays the phenotype MHC-II -CD11b -CD11c -CD31 + CD146 + , was identified as a latently infected cell type expressing IE transcripts, whereas latent viral genomes in the liver did not localize to haematopoietic cell types expressing MHC-II, CD11b or CD11c (Seckert et al., 2009) . Absence of reactivatable, latent mCMV genomes from myeloid lineage stem-and progenitor cells in mouse BM was also suggested from the failure to transmit latent infection by BMT from latently infected donors to naïve recipients . Likewise, for the lungs, recent work by Marquardt et al. (2011) has shown that latent mCMV genomes are enriched in non-haematopoietic CD11b -cells, and mCMV reactivation in lung slice explant cultures excluded fractalkine receptor-expressing CX3CR1 + subsets of the myeloid lineage, including CX3CR1 + pulmonary DCs, as cellular sites of virus reactivation. Taken together, these findings questioned the assumption that memory inflation is driven by direct antigen presentation in latently infected profAPCs.
If, based on these arguments, we presume an absence of direct antigen presentation in profAPCs during mCMV latency, we can think of two alternative modes of antigen presentation for restimulating memory CD8 T-cells: (i) direct antigen presentation by latently infected tissue cells or (ii) cross-presentation of viral antigens, derived from (n542) were confirmed by the Kolmogorov-Smirnov test. The geometric mean values and their 95 % confidence intervals are indicated. P-values (two-tailed) for the differences between the mean values were calculated on the basis of the log-transformed data by using Student's unpaired t-test. latently infected tissue cells, by uninfected profAPCs. If the first alternative applies, IE1-specific memory inflation should not occur in H-2dxdm2 chimeras because the IE1 peptide is not presented by L d-cells. If the second alternative applies, however, IE1-specific memory inflation should take place because the IE1 protein can be processed for peptide presentation in donor-derived L d+ profAPCs, provided that the latently infected L d-tissue cells undergo cell death and release the IE1 protein. The data presented here show a selective failure of IE1-specific memory inflation in H-2dxdm2 chimeras and hence clearly argue against cross-presentation of antigen derived from latently infected tissue cells. Importantly, this failure also argues against a relevant role for direct antigen presentation by a putatively existing minor population of latently infected myeloid lineage profAPCs, for instance by donor-derived tissue resident macrophages reported to be low in expression of CX3CR1 and CD11b (Jung et al., 2000; Vermaelen & Pauwels, 2004) .
Against our interpretation of the data one may argue that, when compared with H-2dxd homo-chimeras, the overall lower amount of IE1 peptide generated during acute infection in H-2dxdm2 chimeras, rather than the type of APC, may later on make the difference in memory inflation. The different amounts of IE1 peptide generated during acute infection, however, were not paralleled by differences in IE1 gene expression during latency. In this Fig. 8 . Activation phenotype of epitope-specific memory CD8 T-cells in latently infected lungs. After resolution of virus replication in the lungs of H-2dxd and H-2dxdm2 chimeras at 15 weeks after BMT and infection (see Fig. 5 ), pulmonary lymphocytes were isolated from a pool of seven lungs per group for a four-colour cytofluorometric analysis (FL, fluorescence). Data are displayed as colour-coded density plots (with red and blue representing highest and lowest density, respectively) using logarithmic threshold calculation. Top panels, in the sideward scatter (SSC, linear scale of channels) versus CD8a expression (log FL-1, FITC) plots, an electronic gate was set on CD8a + cells. Centre panels, percentages of IE1 and m164
epitope-specific cells among the gated CD8 T-cells were determined by staining with the respective, TCR-specific MHCpeptide dextramers (log FL-4, allophycocyanin). Bottom panels, cells within the CD8a + TCR + gates were analysed for expression of the activation markers CD62L (log FL-5, PE-Cy7) and KLRG1 (log FL-2, PE). Percentages of main interest are indicated. *, Reliable analysis was precluded by too low absolute cell number.
context it is important to consider that the amount of peptide processed in productively infected cells is certainly unrelated to the amount of peptide processed in latently infected cells. Actually, the amount of peptide processed during latency does not suffice for detection, because the frequency of latently infected cells in tissues is too low. Likewise, the IE1 protein proved to be below the limit of biochemical and immunohistological detection (Kurz et al., 1999) . In light of this latency-inherent technical dilemma, the internal control provided by an inflationary D d -restricted epitope gains particular importance. As memory inflation specific for the D d -restricted m164 epitope occurred in both types of chimeras, the qualitative difference seen for the IE1 epitope is unlikely to result from a difference in the overall amounts of antigenic proteins expressed.
Previous work by Snyder et al. (2008) has indicated that memory expansion involves continuous replenishment of the memory pool by replacement of short-lived memory cells with progeny of restimulated central memory cells primed already during acute infection as well as by recruitment of naïve cells. As shown here for the specific case of the IE1 epitope, both of these sources appear to be inaccessible or insufficient in H-2dxdm2 BM chimeras. While a missing restimulation of central memory cells is best explained by a lack of IE1-epitope presentation on latently infected tissue cells, missing L d expression on the thymic epithelium might result in a deficiency in the generation of naïve IE1-specific thymic emigrants. Interestingly, however, the quantitative contribution of naïve thymic emigrants to memory inflation needs to be relativised in view of the observation that memory inflation takes place also after thymectomy (noted by Wiesel et al., 2009 ). Although we cannot formally exclude differences in the primary CD8 T-cell repertoires due to the different genotype of the thymic epithelial cells in H-2dxdm2 and H-2dxd chimeras, this potential caveat appears to be minor in view of quantitatively similar priming of IE1-specific CD8 T-cells (Fig. 7) . In any case, our data indicate a critical role of non-haematopoietic host tissue cells for memory inflation to occur. This conclusion is also compatible with recent work by Hutchinson et al. (2011) who presented evidence in support of the view that inflationary epitopes correspond to antigenic peptides that are efficiently generated by the constitutive proteasome present in all cell types, whereas non-inflationary epitopes depend on the immunoproteasome constitutively expressed in profAPCs or conditionally expressed in other cell types upon induction by IFN-c. Accordingly, in the absence of a pro-inflammatory cytokine milieu and provided that the presenting MHC-I molecule and the viral antigenic protein are expressed, the constitutive proteasome present in latently infected nonhaematopoetic host tissue cells will preferentially generate inflationary epitopes and thereby drive memory inflation.
Thus, for memory inflation to occur, at least three conditions need to be fulfilled: (i) expression of the epitope-encoding viral gene, (ii) efficient proteasomal processing for generating the antigenic peptide even from a low amount of protein, preferentially requiring only the constitutive proteasome, and (iii) expression of the MHC-I molecule presenting the antigenic peptide to memory cells.
Collectively, these data strongly support our original hypothesis of memory inflation being driven by repetitive antigen stimulation mediated by episodes of desilencing of certain viral genes in latently infected cells (Holtappels et al., 2000) .
METHODS
Experimental BMT and mCMV infection. BMT and infection were performed as described previously with no depletion of BM-resident T-cells (Podlech et al., 2002) . In essence, 8-week-old female mice received haematoablative total-body c-irradiation with a single dose of 6.5 Gy. BMT was performed 6 h later by infusion of 5610 6 femoral and tibial male donor-derived BM cells into the tail vein of the recipients. Intraplantar infection of the recipients with 10 5 p.f.u. of wild-type (WT) virus mCMV-WT.Smith (strain Smith ATCC VR-1399) was performed 2 h after BMT. Animal experiments were approved according to German federal law under permission number 177-07/G09-1-004.
Preparation of lung cell suspensions. Lung cells were isolated by using a modification of the method described in . The lungs were perfused via the right ventricle with perfusion solution [Gey's balanced salt solution (GBSS)+0.2 U collagenase A ml 21 (catalogue no. 10103586001; Roche)]. The lungs were excised, tracheae, bronchi and pulmonary lymph nodes were removed and the five lung lobes were minced with scissors. Digestion of tissue was performed in 15 ml GBSS+0.2 U collagenase A ml 21 +1000 U DNase I (catalogue no. 11284932001; Roche) for 2 h at 37 uC in a rotating water bath. Tissue clumps were resolved by straining the digested tissue through a steel mesh and thereafter through a 100 mm nylon mesh. After lysis of red blood cells, the cell suspension was strained through a 40 mm nylon mesh.
Separation and phenotypic analysis of lung and spleen cell suspensions. The following MicroBeads and reagents were used for (immuno)magnetic cell separation and cytofluorometric analysis: rat anti-mouse CD146 MicroBeads (clone ME-9F1, rat IgG2a, 20 ml per 10 7 cells; catalogue no. 130-092-007; Miltenyi Biotec), rat anti-mouse MHC-II MicroBeads (rat IgG2b, 10 ml per 10 7 cells; catalogue no. 130-052-401; Miltenyi Biotec), mouse anti-mouse H-2D d FITCconjugated (clone 34-2-12, mouse IgG2a, 1 mg per 10 6 cells; catalogue no. 553579; BD Biosciences), mouse anti-mouse H-2L d PE-conjugated (clone 30-5-7S, mouse IgG2a, 1 mg per 10 6 cells; catalogue no. CL9011PE; Cedarlane), rat anti-mouse CD8a PE-Cy5-conjugated (clone 53-6.7, 0.3 mg per 10 6 cells, rat IgG2a; catalogue no. 553034; BD Biosciences), hamster anti-mouse CD11c PE-Cy7-conjugated (clone N418, 0.5 mg per 10 6 cells, hamster IgG; catalogue no. 25-0114; eBioscience), rat anti-mouse CD8a FITC-conjugated (clone 53-6.7, 0.5 mg per 10 6 cells, rat IgG2a; catalogue no. 553031; BD Biosciences), hamster anti-mouse KLRG1 PE-conjugated (clone 2F1, 0.2 mg per 10 6 cells, hamster IgG; catalogue no. 12-5893-82; eBioscience), rat antimouse CD62L PE-Cy7-conjugated (clone MEL-14, 0.3 mg per 10 6 cells, rat IgG2a; catalogue no. 731715; Beckman Coulter), MHCpeptide dextramer H-2Ld-IE1(YPHFMPTNL) allophycocyanin-conjugated (10 ml per 10 6 cells; code no. JG3532-APC; Immudex), and MHC-peptide dextramer H-2Dd-m164 (AGPPRYSRI) allophycocyaninconjugated (10 ml per 10 6 cells; code no. JB3533-APC; Immudex).
(i) Immunomagnetic cell sorting. For quantification of donor-derived sry + cells, cell populations positive for MHC-II or CD146 were enriched from lung cell suspensions by magnetic cell sorting (Seckert et al., 2009) .
(ii) Four-colour cytofluorometric analysis. Cells were labelled with the indicated directly fluorochrome-conjugated mAbs and MHCpeptide multimers (dextramers) for cytofluorometric analysis performed with a Beckman Coulter FC500 and CXP software, version 2.2 (Beckman Coulter).
Quantification of genomes and transcripts. BM cells were isolated by flushing one tibia (individual mouse testing) with 1 ml PBS. DNA from BM cells, lung tissue pieces or immunomagnetically enriched lung cell subsets was extracted with a DNeasy Blood & Tissue kit (Qiagen) (Seckert et al., 2009) . Quantification of the viral gene M55/gB, the cellular gene pthrp and the Y-chromosomal gene sry was performed by SYBR-Green qPCR . Standard curves for quantification were established by using graded numbers of linearized plasmid pDrive_gB_PTHrP_Tdy (Simon et al., 2005) as template. RT-qPCR for quantifying spliced IE1 transcripts has been described in detail previously (Lemmermann et al. 2010) .
Quantification of naturally processed IE1-peptide in infected lungs. Naturally processed peptides were acid-extracted and separated by reversed-phase HPLC, essentially as described previously (Holtappels et al., 2002a (Holtappels et al., , 2009 ). The IE1 peptide elutes with a peak in fraction 29. Aliquots of the HPLC fractions were used for pulsing TAPdeficient T2-L d transfectants for a cytolytic assay with an IE1-specific CTL line. IE1 peptide quantities were estimated from a standard curve obtained with defined concentrations of synthetic IE1 peptide.
Genome-wide ORF library screening. An mCMV ORF library of expression plasmids spanning the whole mCMV genome (Munks et al., 2006b ) was employed for ORF-specific stimulation of ex vivo isolated CD8 T-cells with transfectants followed by cytofluorometric detection of intracellular IFN-c as described in detail previously (Lemmermann et al., 2010) . A list allocating library numbers to ORFs can be found in Holtappels et al. (2008b) .
ELISpot assay. Frequencies of epitope-specific CD8 T-cells were determined by an IFN-c-based ELISpot assay (Holtappels et al., 2008b; Pahl-Seibert et al., 2005) . In brief, graded numbers of immunomagnetically purified CD8 T-cells were sensitized in triplicate assay cultures by incubation with P815 mastocytoma cells as stimulator cells exogenously loaded with synthetic peptides at optimized concentrations. Frequencies of IFN-c-secreting cells and the corresponding 95 % confidence intervals were calculated by intercept-free linear regression analysis (Böhm et al., 2008; PahlSeibert et al., 2005) .
